创新药，大消息！刚刚，国家医保局宣布

Group 1 - The first version of the commercial insurance innovative drug directory will be officially released on the first weekend of December [1] - From October 30 to November 3, the National Healthcare Security Administration organized negotiations for the 2025 National Basic Medical Insurance Drug Directory and price negotiations for the commercial insurance innovative drug directory, with 120 domestic and foreign companies participating [2] - The new basic medical insurance drug directory and the first version of the commercial insurance innovative drug directory are expected to be released online and offline in Guangzhou, with implementation starting on January 1 of the following year [2] Group 2 - The establishment of the commercial insurance innovative drug directory has become a focal point in the industry, aimed at improving the accessibility of innovative drugs [3] - In 2023, the payment structure for innovative drugs in China shows that personal payments account for 49%, basic medical insurance for 44%, and commercial health insurance for only 7% [3]